上海复星医药（集团）股份有限公司
Summary
上海复星医药（集团）股份有限公司 is registered in China and entered in the “National Enterprise Credit Information Publicity System” under number 913100001330605412. Its legal form is 企业 – enterprise (China). 上海复星医药（集团）股份有限公司 is the ultimate parent of a group of 1 subsidiary in 2 countries, as reported to GLEIF. GLEIF gives this reason: the entity is controlled by legal entities that are not subject to accounting consolidation. It has 1 direct subsidiary in GLEIF data; 1 of them has a lapsed LEI. The LEI was first issued on 26 Feb 2020 and the record was last updated on 22 Feb 2023. It has lapsed: renewal was due by 22 Feb 2024. AssetCensus found 1 data-quality note for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 22 Feb 2024 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
Company details
| Legal form | 企业 enterprise (China) |
|---|---|
| Register | National Enterprise Credit Information Publicity System · Register website |
| Registration number | 913100001330605412 |
| Registration authority | State Administration for Market Regulation |
| Jurisdiction | China |
| Registered address | 曹杨路510号9楼, 100000 普陀区, China |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 31 May 1995 |
| LEI | 300300DMUYLW3FP1OT73 |
| LEI status | lapsed |
| LEI first issued | 26 Feb 2020 |
| LEI record last updated | 22 Feb 2023 |
| Next LEI renewal | 22 Feb 2024 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Parent not reported to GLEIF
- Direct parent: the entity is controlled by legal entities that are not subject to accounting consolidation.
- Ultimate parent: the entity is controlled by legal entities that are not subject to accounting consolidation.
Direct subsidiaries (1)
- 美中互利香港有限公司 Hong Kong lapsed · 香港